Search Tag: dostarlimab

IMAGING Management

Cancer-vanishes-for-every-patient-with-dostarlimab

2022 08 Jun

A small group of patients with rectal cancer have experienced a scientific miracle - a cancer drug that made their cancer vanish completely.  In a small trial at Memorial Sloan Kettering Cancer Center, patients with rectal cancer received dostarlimab, an anti–PD-1 monoclonal antibody, administered every three weeks for six months. The trial included...Read more